THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES

by N. Z. Musina, V. K. Fedyaeva
Published 2017-05-01

PROSPECTS FOR THE USE OF METHODS OF ECONOMIC EVALUATION AT THE STAGE OF PLANNING AND ORGANISATION OF CLINICAL TRIALS

by N. Z. Musina, V. V. Tarasov
Published 2016-04-01

Evaluation of the reference value of the incremental parameter "cost-effectiveness" for Russian healthcare system

by T. S. Teptsova, N. Z. Musina, V. V. Omelyanovsky
Published 2021-02-01

IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET

by V. A. Lemeshko, N. Z. Musina, V. K. Fedyaeva
Published 2018-02-01

EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS

by N. Z. Musina, V. V. Omelyanovskiy, A. V. Krasheninnikova
Published 2016-12-01

Introduction of medical products into healthcare practice and costs reimbursement: European experience

by V. V. Omelyanovsky, S. S. Otstavnov, N. Z. Musina, V. S. Dombrovskii
Published 2018-08-01

The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia

by V. V. Omelyanovsky, V. K. Fedyaeva, N. Z. Musina
Published 2018-11-01

Evaluation of the antitumor drugs therapeutic value using the method of multicriterial analysis of decision-making

by V. A. Lemeshko, N. Z. Musina, V. V. Omelyanovskiy
Published 2020-11-01

Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions

by G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina
Published 2019-01-01

Evolution of healthcare provider payment mechanisms

by V. V. Omelyanovskiy, N. N. Sisigina, V. K. Fedyaeva, N. Z. Musina
Published 2020-02-01

Affordability of in vivo gene therapy. Problems and potential solutions

by V. V. Omelyanovskiy, N. Z. Musina, V. A. Lemeshko, A. A. Antonov, F. V. Gorkavenko
Published 2020-08-01

Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies

by T. S. Teptsova, T. P. Bezdenezhnyh, V. K. Fedyaeva, N. Z Musina, G. R. Hachatryan, V. V. Tarasov
Published 2018-11-01

International experience in determining the cost-effectiveness thresholds

by T. P. Bezdenezhnykh, N. Z. Musina, V. K. Fedyaeva, T. S. Tepcova, V. A. Lemeshko, V. V. Omelyanovsky
Published 2019-01-01

THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS

by V. K. Fedyaeva, V. V. Omelyanovskiy, N. Z. Musina, G. R. Khachatryan, O. I. Ivakhnenko
Published 2017-08-01

Concept of value-based healthcare

by N. Z. Musina, V. V. Omelyanovskiy, R. V. Gostischev, O. A. Sukhorukikh, V. K. Fedyaeva, N. N. Sisigina, D. G. Shchurov
Published 2021-02-01

Review of the current approaches to the assessment of the drug innovative potential worldwide

by N. Z. Musina, V. K. Fedyaeva, V. V. Omel’yanovskii, G. R. Khachatryan, K. V. Gerasimova, V. A. Lemeshko, K. P. Konchits
Published 2017-11-01